|4Jun 9, 4:47 PM ET

Looker Benjamin 4

4 · Esperion Therapeutics, Inc. · Filed Jun 9, 2022

Insider Transaction Report

Form 4
Period: 2022-06-07
Looker Benjamin
General Counsel
Transactions
  • Award

    Stock Option (right to buy)

    2022-06-07+52,00052,000 total
    Exercise: $6.20Exp: 2032-06-07Common Stock (52,000 underlying)
Footnotes (1)
  • [F1]Such award shall vest upon obtaining approval for cardiovascular risk reduction into the U.S. label.

Documents

2 files
  • 4
    wf-form4_165480763554748.xmlPrimary

    FORM 4

  • EX-24

    LOOKER POA